Epstein-Barr virus (EBV) is ubiquitous and carried by approximately 90% of the world's adult
population. Several mechanisms and pathways have been proposed as to how EBV …

Epstein–Barr virus (EBV) contributes to about 1.5% of all cases of human cancer worldwide,
and viral genes are expressed in the malignant cells. EBV also very efficiently causes the …

Epstein-Barr virus (EBV) infection is associated with a variety of malignancies including
Burkitt's lymphoma (BL), Hodgkin's disease, T cell lymphoma, nasopharyngeal carcinoma …

Based on their genomic organisation, tissue tropism, and other biological characteristics,
herpesviruses are classified into three categories: α, β, and γ. Of these, the γ-herpesviruses …

Epstein-Barr virus (EBV) is a ubiquitous, oncogenic virus that is associated with a number of
different human malignancies as well as autoimmune disorders. The expression of EBV viral …

The Epstein–Barr virus (EBV) is the first herpesvirus identified to be associated with human
cancers known to infect the majority of the world population. EBV-associated malignancies …

Epstein–Barr virus (EBV) is the first identified human oncogenic virus that can establish
asymptomatic life-long persistence. It is associated with a large spectrum of diseases …

Abstract The association of Epstein-Barr virus (EBV) with various malignancies is well
established but the pattern of EBV latent gene expression in these different tumours is …

Introduction 3. Genetics of EBV 3.1. Genome structure 3.2. EBV strain variations 4. EBV
primary infection and persistence 4.1. In vitro models of EBV infection 4.2. EBV persistence …

It is more than 50 years since the Epstein–Barr virus (EBV), the first human tumour virus, was
discovered. EBV has subsequently been found to be associated with a diverse range of …